Viewray Inc 's ability to collect accounts receivable sequentially worsen to 3.04, indicating more challenging environment then in the fourth quarter 2022, but still, it is a far cry from any concerns. Viewray Inc 's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 120 days, from 101 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 299 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 2350 to 2356.

What is Receivable Turnover Ratio?
What is Viewray Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VRAY Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	116.25 %	168.44 %	73.2 %	84.03 %	-17.21 %
Y / Y Revenue Change	19.38 %	70.16 %	38.13 %	47.37 %	21.58 %
Receivable Turnover Ratio (TTM)	3.04	3.6	4.01	4.26	4.47
VRAY's Total Ranking	# 2356	# 2350	#	#	#
Accounts Receivable average collection period days	120	102	91	86	82
Seq. Receivable Change	14.85 %	44.2 %	32.5 %	-1.45 %	42.57 %
Seq. Revenue Change	-35.04 %	30.96 %	19.6 %	17.34 %	-7.41 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 125
Healthcare Sector	# 300
Overall Market	# 2356

Receivable Turnover Ratio Statistics
High	Average	Low
0.45	0.23	0
(Dec 31 2022)		(Sep 30 2016)

VRAY Company Profile • Back to VRAY Efficiency Comparisons • Compare VRAY Receivables Turnover Ratio to its Competitors

Financial Statements
Viewray Inc 's Accounts Receivable	$ 48 Millions	Visit VRAY's Balance sheet
Viewray Inc 's Sales TTM	$ 106 Millions	Visit VRAY's Income Statement
Sources of VRAY's Revenues		Visit VRAY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VRAY's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VRAY's Growth Rates	VRAY's Roa	VRAY's Inventory Turnover Ratio	VRAY's Dividend Comparisons
VRAY's Profitability Ratios	VRAY's Roi	VRAY's Asset Turnover Ratio	VRAY's Dividend Growth
VRAY's Valuation Ratios	VRAY's Roe	VRAY's Financial Strength Ratios	VRAY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Xtant Medical Holdings Inc	6.11	$ 62.953 Millions	$ 10.299 Millions
Mettler toledo International Inc	6.11	$ 3,950.656 Millions	$ 646.841 Millions
The Cooper Companies Inc	6.10	$ 3,427.300 Millions	$ 561.975 Millions
Sintx Technologies Inc	6.09	$ 1.970 Millions	$ 0.323 Millions
Clever Leaves Holdings Inc	6.08	$ 16.554 Millions	$ 2.721 Millions
Adaptive Biotechnologies Corporation	6.08	$ 184.335 Millions	$ 30.323 Millions
Dentsply Sirona Inc	6.07	$ 3,931.000 Millions	$ 647.500 Millions
Community Health Systems Inc	6.06	$ 12,208.000 Millions	$ 2,013.250 Millions
Jazz Pharmaceuticals Plc	6.05	$ 3,738.465 Millions	$ 617.661 Millions
Novocure Limited	6.04	$ 522.475 Millions	$ 86.552 Millions
Steris Plc	6.02	$ 4,957.839 Millions	$ 823.744 Millions
Champions Oncology Inc	6.01	$ 53.870 Millions	$ 8.957 Millions
Pacific Health Care Organization Inc	6.01	$ 5.630 Millions	$ 0.936 Millions
Cutera Inc	6.00	$ 248.017 Millions	$ 41.333 Millions
Hologic Inc	5.99	$ 4,056.400 Millions	$ 677.075 Millions
Surgery Partners Inc	5.99	$ 2,609.300 Millions	$ 435.875 Millions
Neogen Corporation	5.98	$ 720.730 Millions	$ 120.473 Millions
Cytomx Therapeutics Inc	5.98	$ 59.526 Millions	$ 9.951 Millions
Treace Medical Concepts Inc	5.98	$ 133.929 Millions	$ 22.403 Millions
Amphastar Pharmaceuticals Inc	5.97	$ 518.641 Millions	$ 86.838 Millions
Johnson and Johnson	5.97	$ 96,263.000 Millions	$ 16,134.750 Millions
Interpace Biosciences Inc	5.96	$ 31.287 Millions	$ 5.246 Millions
Merck and Co Inc	5.94	$ 57,869.000 Millions	$ 9,747.500 Millions
Bruker Corporation	5.93	$ 2,621.000 Millions	$ 442.075 Millions
Bio rad Laboratories Inc	5.93	$ 2,779.031 Millions	$ 468.886 Millions
Nevro Corp	5.90	$ 414.850 Millions	$ 70.283 Millions
Neuropace Inc	5.89	$ 48.618 Millions	$ 8.257 Millions
Stereotaxis Inc	5.89	$ 27.658 Millions	$ 4.697 Millions
Baxter International Inc	5.88	$ 15,055.000 Millions	$ 2,558.500 Millions
Livanova Plc	5.88	$ 1,045.048 Millions	$ 177.618 Millions

Date modified: 2026-09-02T20:05:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.